Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2007; 13(10): 1579-1584
Published online Mar 14, 2007. doi: 10.3748/wjg.v13.i10.1579
Published online Mar 14, 2007. doi: 10.3748/wjg.v13.i10.1579
Variables | Subjects withoutNAFLD(n = 1335) | Subjects withNAFLD(n = 312) | P |
Asparate aminotransferase, U/L | 17.4 ± 5.2 | 23.9 ± 11.2 | < 0.001 |
Alanine aminotransferase, U/L | 17.7 ± 9.6 | 38.8 ± 27.8 | < 0.001 |
Gamma-glutamyltransferase, U/L | 17.8 ± 18.2 | 34.0 ± 31.5 | < 0.001 |
Men, n (%) | 730 (54.7) | 250 (80.1) | < 0.001 |
Age (yr) | 47.8 ± 8.6 | 49.1 ± 8.7 | 0.017 |
The Brinkman index1 | 223.8 ± 359.3 | 358.6 ± 461.9 | < 0.001 |
LDL-C, mmol/L | 3.4 ± 0.8 | 3.7 ± 0.9 | < 0.001 |
The metabolic syndrome, n (%) | 87 (6.5) | 119 (38.1) | < 0.001 |
BMI, kg/m2 | 21.9 ± 2.6 | 25.1 ± 2.5 | < 0.001 |
Fasting plasma glucose, mmol/L | 5.1 ± 0.6 | 5.7 ± 1.3 | < 0.001 |
Systolic blood pressure, mmHg | 114.6 ± 16.2 | 123.7 ± 15.9 | < 0.001 |
Diastolic blood pressure, mmHg | 71.6 ± 10.2 | 77.8 ± 9.7 | < 0.001 |
HDL-C, mmol/L | 1.3 ± 0.3 | 1.0 ± 0.2 | < 0.001 |
Triglycerides, mmol/L | 1.2 ± 0.7 | 1.9 ± 1.0 | < 0.001 |
C reactive protein, mg/dL | 0.1 ± 0.4 | 0.2 ± 0.3 | 0.19 |
Odds ratio (95% CI) | P | |
NAFLD | 5.37 (2.29-12.58) | < 0.001 |
Gamma -glutamyltransferase, U/L | 1.02 (1.01-1.03) | < 0.001 |
Age, 10 yr | 2.30 (1.46-3.61) | < 0.001 |
Men | 1.70 (0.66-4.38) | 0.27 |
The Brinkman index, 100 index1 | 1.08 (1.00-1.17) | 0.049 |
LDL-C, mmol/L | 1.48 (0.89-2.46) | 0.13 |
The metabolic syndrome | 3.14 (1.26-7.83) | 0.014 |
The components of metabolic syndrome | ||
BMI, kg/m2 | 1.14 (1.00-1.31) | 0.044 |
Fasting plasma glucose, mmol/L | 1.42 (1.01-2.01) | 0.046 |
Systolic blood pressure, 10 mmHg | 1.72 (1.4-2.12) | < 0.001 |
Diastolic blood pressure, 10 mmHg | 2.31 (1.57-3.39) | < 0.001 |
HDL-C, mmol/L | 0.16 (0.03-0.84) | 0.031 |
Triglycerides, mmol/L | 1.61 (1.11-2.32) | 0.012 |
Total (n = 1221) | Model 1 | Model 2 | Model 3 | |||
Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | |
NAFLD | 3.57 (1.47-8.67) | 0.005 | (-) | (-) | 4.12 (1.58-10.75) | 0.004 |
The metabolic syndrome | (-) | (-) | 2.61 (1.03-6.60) | 0.042 | 1.38 (0.49-3.86) | 0.54 |
Age, 10 yr | 1.61 (0.97-2.66) | 0.064 | 2.08 (1.30-3.33) | 0.002 | 2.12 (1.32-3.41) | 0.002 |
The Brinkman index, 100 index1 | 1.06 (0.97-1.16) | 0.18 | 1.05 (0.96-1.14) | 0.28 | 1.03 (0.95-1.12) | 0.48 |
Systolic blood pressure, 10 mmHg | 1.60 (1.26-2.04) | < 0.001 | (-) | (-) | (-) | (-) |
LDL-C, mmol/L | 1.19 (0.70-2.03) | 0.52 | 1.35 (0.8-2.3) | 0.26 | 1.24 (0.73-2.08) | 0.43 |
Men (n = 748) | Model 1 | Model 2 | Model 3 | |||
Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | |
NAFLD | 2.78 (0.98-7.89) | 0.054 | (-) | (-) | 3.56 (1.16-10.95) | 0.027 |
The metabolic syndrome | (-) | (-) | 2.06 (0.70-6.11) | 0.19 | 1.13 (0.34-3.78) | 0.84 |
Age, 10 yr | 1.59 (0.90-2.80) | 0.11 | 1.90 (1.11-3.23) | 0.019 | 1.96 (1.15-3.34) | 0.014 |
The Brinkman index, 100 index1 | 1.07 (0.97-1.18) | 0.19 | 1.05 (0.95-1.15) | 0.35 | 1.04 (0.95-1.13) | 0.44 |
Systolic blood pressure, 10 mmHg | 1.51 (1.10-2.07) | 0.011 | (-) | (-) | (-) | (-) |
LDL-C, mmol/L | 1.42 (0.74-2.71) | 0.29 | 1.53 (0.81-2.90) | 0.19 | 1.42 (0.76-2.65) | 0.27 |
Women (n = 473) | Model 1 | Model 2 | Model 3 | |||
Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | |
NAFLD | 14.33 (1.98-103.57) | 0.008 | (-) | (-) | 7.32 (1.22-43.84) | 0.029 |
The metabolic syndrome | (-) | (-) | 4.59 (0.78-27.10) | 0.093 | 2.86 (0.42-19.39) | 0.28 |
Age, 10 yr | 1.87 (0.60-5.78) | 0.28 | 3.28 (1.09-9.86) | 0.035 | 3.04 (0.99-9.31) | 0.051 |
The Brinkman index, 100 index1 | 0.46 (0.03-6.76) | 0.57 | 0.55 (0.04-7.63) | 0.65 | 0.41 (0.03-6.44) | 0.53 |
Systolic blood pressure, 10 mmHg | 1.88 (1.23-2.86) | 0.003 | (-) | (-) | (-) | (-) |
LDL-C, mmol/L | 0.62 (0.21-1.85) | 0.39 | 0.87 (0.30-2.52) | 0.80 | 0.77 (0.27-2.16) | 0.62 |
- Citation: Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13(10): 1579-1584
- URL: https://www.wjgnet.com/1007-9327/full/v13/i10/1579.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i10.1579